Rational Design of a MAP 34‐B‐Derived Peptide Confers Potent Membrane‐Targeting Activity against Escherichia coli and Acinetobacter baumannii With Improved Biocompatibility
Journal of Peptide Science · 2026-12 · 32 (12)
DOI: 10.1002/psc.70147 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Peptide Science, online erschienen am 03.11.2026. Verfasst von Junnan Dai und 6 weiteren Autor:innen. Beteiligte Einrichtung: Center for Evolution and Conservation Biology, Southern Marine Science and Engineering Guangdong Laboratory (Guangzhou), Guangzhou, Guangdong, China. Hauptthemen laut MEDLINE: Acinetobacter baumannii, Escherichia coli, Anti-Bacterial Agents, Antimicrobial Cationic Peptides. Die Arbeit nennt 94 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Key-Area Research and Development Program of Guangdong Province, Guangxi Key Research and Development Program.
Abstract (Originalsprache)
The global spread of antimicrobial resistance, particularly among clinically important Gram‐negative pathogens, has intensified the search for effectives to conventional antibiotics. Antimicrobial peptides are promising, as they act rapidly on bacterial envelopes and may circumvent resistance. Here, we rationally designed two derivatives of MAP 34‐B, MAP 34B‐1, and MAP 34B‐2 and comparatively evaluated their antibacterial activity, physicochemical stability, membrane‐associated mechanism, and cytocompatibility. MAP 34B‐1 displayed stronger and broader activity against Escherichia coli and Acinetobacter baumannii than MAP 34B‐2 and rapidly reduced bacterial viability within 2 h. In contrast, MAP 34B‐2 exhibited a narrower antibacterial spectrum and weaker activity against A. baumannii . Scanning electron microscopy revealed morphological damage of bacterial cells, FITC‐labeled peptide localization confirmed membrane binding, and membrane permeability assays demonstrated disruption of membrane integrity. Collectively, these results support a membrane‐associated antibacterial mechanism for MAP 34B‐1. Both derivatives retained antibacterial activity under the tested salt and thermal conditions. Notably, MAP 34B‐1 caused less mammalian‐cell cytotoxicity and hemolysis than MAP 34B‐2, resulting in a more favorable balance between antibacterial potency and host‐cell compatibility. Overall, these findings demonstrate that rational sequence optimization of MAP 34‐B can substantially modulate antibacterial spectrum, membrane activity, and biocompatibility. MAP 34B‐1 therefore represents a promising lead peptide for further development against infections caused by E. coli and A. baumannii .
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Evolution and Conservation Biology, Southern Marine Science and Engineering Guangdong Laboratory (Guangzhou), Guangzhou, Guangdong, China.
- School of Life Sciences and Medical Engineering, Anhui University, Hefei, Anhui, China.
- Department of Rheumatology and Immunology, The First People's Hospital of Yunnan Province, Kunming University of Science and Technology Affiliated Hospital, Kunming, Yunnan, China.
ORCID-Profile: Yue Peng, Miaoqin Lin, Jiaming Zhang, Aili Wang
Förderung
- National Natural Science Foundation of China
- Key-Area Research and Development Program of Guangdong Province
- Guangxi Key Research and Development Program
Zitieren
APA
Dai, J., Chen, Z., Peng, Y., Lin, M., Zhang, J., He, F., & Wang, A. (2026). Rational Design of a MAP 34‐B‐Derived Peptide Confers Potent Membrane‐Targeting Activity against Escherichia coli and Acinetobacter baumannii With Improved Biocompatibility. Journal of Peptide Science, 32(12). https://doi.org/10.1002/psc.70147
Vancouver
Dai J, Chen Z, Peng Y, Lin M, Zhang J, He F, et al. Rational Design of a MAP 34‐B‐Derived Peptide Confers Potent Membrane‐Targeting Activity against Escherichia coli and Acinetobacter baumannii With Improved Biocompatibility. Journal of Peptide Science. 2026;32(12). doi:10.1002/psc.70147
BibTeX
@article{Dai2026,
author = {Dai, Junnan and Chen, Zihui and Peng, Yue and Lin, Miaoqin and Zhang, Jiaming and He, Fang and Wang, Aili},
title = {Rational Design of a MAP 34‐B‐Derived Peptide Confers Potent Membrane‐Targeting Activity against Escherichia coli and Acinetobacter baumannii With Improved Biocompatibility},
journal = {Journal of Peptide Science},
year = {2026},
volume = {32},
number = {12},
doi = {10.1002/psc.70147}
}
EUVIMED